Trial Profile
A Phase II, Randomized, Open-Label, Single Center, Pharmacokinetic and Pharmacodynamic Study of Dexmedetomidine in Pediatric Subjects Aged 12 Months Through <24 Months
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Hospira
- 03 Mar 2017 New trial record